The size of the global ocular implants market is predicted to grow at a CAGR of 7.2% from 2024 to 2029.
Ocular implants are medical instruments used for vision correction purposes. Various kinds of implants are available for eye diseases and disorders in patients.
The rising incidence of cataracts worldwide is a significant factor contributing to the growth of the global ocular implants market. A cataract is one of the common problems seen and is expected to surge in upcoming years. According to the evaluation done by the CDC, cataract cases are estimated to rise to 30.1 million in the United States by 2050. The increasing aging population, growing correction cases of vision in children and adults, and technological developments in this area are further expected to propel the ocular implants market growth globally. Expansion in alertness among people and rise in government initiatives for vision care management are projected to escalate the market growIn addition, increasing incidences of chronic diseases are urging the growth rate of the market.
Difficulties associated with implantation and post-implantation are impeding the market growth globally. The shortage of skilled surgeons to implement the procedures is restraining the market growth during the time frame.
The outbreak of the COVID-19 pandemic affected the medical field in various aspects, and patients with various chronic diseases such as diabetes, lung diseases, and cardiovascular diseases are at higher risk of ocular implants. The American Academy of Ophthalmology released guidelines regarding emergency and non-emergency cases. Since the start of COVID-19, there has been a surge in demand for the ocular implants market.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Implant Type, Application, End-User and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Bausch & Lomb, Alcon, Carl Zeiss, Johnson & Johnson |
Based on implant type, the glaucoma implants segment had the leading share of the market in 2023.The Intraocular lenses segment is projected to have the quickest growth in the global ocular implants market during the forecast period.
Based on the application, the glaucoma surgery segment accounts for a considerable share of the worldwide market owing to the growing consciousness regarding eye diseases among people.The age-related macular degeneration segment is considered to be the quickest-growing segment in the market. Advancements in technology and common AMD are projected to augment the segment growth in the market.
Based on the End-User, the hospital segment had a leading share in the global market in 2023 among all the other segments. The growing regularity of treatment for vision impairment in hospitals and the large patient count affected with eye-relevant diseases integrated with experienced physicians is predicted to surge the market segment's growth globally.Specialty eye institutes are predicted to be the quickest-growing segment because of the expanding need for eye care services in rural areas.
Geographically, the global ocular implants market was dominated by North America, closely followed by Europe. Asia Pacific is expected to grow at a high CAGR. Increasing adoption of advanced ocular implants and rising key players' focus on launching eyewear in the U.S. are majorly supporting the market in this region. The United States accounted for the major in the North American market in 1019 due to the high population base that has supportive insurance coverage and technological advancements. The Canadian market of ocular implants is expected to showcase a substantial growth rate during the forecast period.
The European market is projected to be positioned as the second-largest market for ocular implants due to the rise in the aging population, technological developments, and burgeoning cases of ocular disorders. The UK is estimated to lead the European market. This country has increased awareness associated with glaucoma diseases and the need for early glaucoma surgical treatment to augment the region's market growth.
Asia-Pacific is projected to develop at a quick pace during the forecast period and is assumed as the fastest-growing region in the global ocular implants market. Rise in senior citizens population and frequency of cataracts and glaucoma in countries like China, Japan, and India. The surge in the spread of awareness associated with ocular implants, incorporated with the growing availability of IOL and glaucoma devices, is fueling the market growth in the region. Moreover, an acceptable patient population and improving healthcare infrastructure in the area are impelling the market region.
The ocular implants market's Latin American market is projected to hike at a steady rate between 2020 to 2025. The market growth is attributed to factors such as the high number of regulatory clearances for ocular devices and advancements in eye diagnostic technology leading to extensive product assumptions. Brazil is leading the ocular implants market with an average share.
The ocular implants market in the Middle East & Africa is projected to have the least share. Increasing targeted huge old age population and minimum funds and investments for research and development related to healthcare to the eye research institutes bolstered market growth.
Some of the most promising companies leading the global ocular implants market profiled in this report are Bausch & Lomb, Alcon, Carl Zeiss, Johnson & Johnson, MORCHER GmbH, and STAAR Surgical.
This research report on the global ocular implants market has been segmented and sub-segmented based on the implant type, application, end-user, and region.
By Implant Type
By Application
By End User
By Region
Frequently Asked Questions
North America is the largest market for ocular implants, followed by Europe and Asia Pacific.
The growing prevalence of eye disorders and diseases, rising demand for minimally invasive surgeries, and technological advancements in ocular implant devices primarily boost market growth.
Alcon, Inc., Bausch & Lomb, Inc., Carl Zeiss Meditec AG, Johnson & Johnson, STAAR Surgical Company, and Topcon Corporation are some of the key players in the ocular implants market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region